Source: Annual Congress 2004 - Community acquired pneumonia
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Takayanagi, T. Kato, D. Tokunaga, H. Matsushima, M. Ubukata, K. Kurashima, T. Yanagisawa, Y. Sugita (Saitama, Japan). Efficacy of the neuraminidase inhibitors in treating influenza pneumonia. Eur Respir J 2004; 24: Suppl. 48, 1182

Member's Comments

No comment yet.

Related content which might interest you: Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients Source: Eur Respir J 2015; 45: 1642-1652 Year: 2015 Comparison between community acquired pneumonia and influenza H1N1 pneumonia Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir Source: Eur Respir J 2014; 44: 535-537 Year: 2014 Influenza pneumonia: a comparison between seasonal influenza virus and the H1N1 pandemic Source: Eur Respir J 2011; 37: 106-111 Year: 2011 Efficacy of influenza and pneumococcal vaccinations among patients with COPD Source: Annual Congress 2007 - Treatment of COPD Year: 2007 Long-term outcomes after viral pneumonia caused by influenza A (H1N1) Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Cytokine response in pediatric patients with pandemic H1N1 influenza virus infection and pneumonia: Comparison with pediatric pneumonia without H1N1 infection Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection Year: 2011 Influenza: vaccination and treatment Source: Eur Respir J 2001; 17: 1282-1293 Year: 2001 Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia. Source: International Congress 2019 – Clinical challenges in respiratory infection Year: 2019 Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Inhaled corticosteroids and influenza A (H1N1) viral pneumonia Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012 Early diagnosis and causal treatment of pneumonia associated with pandemic influenza A (H1N1) virus Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era Year: 2020 Early clinical abnormalities after H1N1 influenza pneumonia Source: Annual Congress 2011 - Influenza A (H1N1): lessons after the epidemic Year: 2011 Impact of influenza vaccination in patients with CAP Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Outcome of influenza vaccination in elderly with pneumonia Source: International Congress 2019 – Airway infection in COPD Year: 2019 Evaluation of pneumonia cases due to pandemic influenza A (H1N1) Source: Annual Congress 2010 - Influenza A (H1N1): epidemiology Year: 2010 Clinical relevance of mixed respiratory viral infections in adults with influenza A H1N1 Source: Eur Respir J 2011; 38: 739-742 Year: 2011 Influenza H1N1 with pneumonia Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010